Medaus Compounding Pharmacy
Identification of late-onset hypogonadism in middle-aged and elderly men - Abstract PDF Print E-mail

The association between aging-related testosterone deficiency and late-onset hypogonadism in men remains a controversial concept.

We sought evidence-based criteria for identifying late-onset hypogonadism in the general population on the basis of an association between symptoms and a low testosterone level.

We surveyed a random population sample of 3369 men between the ages of 40 and 79 years at eight European centers. Using questionnaires, we collected data with regard to the subjects' general, sexual, physical, and psychological health. Levels of total testosterone were measured in morning blood samples by mass spectrometry, and free testosterone levels were calculated with the use of Vermeulen's formula. Data were randomly split into separate training and validation sets for confirmatory analyses.

In the training set, symptoms of poor morning erection, low sexual desire, erectile dysfunction, inability to perform vigorous activity, depression, and fatigue were significantly related to the testosterone level. Increased probabilities of the three sexual symptoms and limited physical vigor were discernible with decreased testosterone levels (ranges, 8.0 to 13.0 nmol per liter [2.3 to 3.7 ng per milliliter] for total testosterone and 160 to 280 pmol per liter [46 to 81 pg per milliliter] for free testosterone). However, only the three sexual symptoms had a syndromic association with decreased testosterone levels. An inverse relationship between an increasing number of sexual symptoms and a decreasing testosterone level was observed. These relationships were independently confirmed in the validation set, in which the strengths of the association between symptoms and low testosterone levels determined the minimum criteria necessary to identify late-onset hypogonadism.

Late-onset hypogonadism can be defined by the presence of at least three sexual symptoms associated with a total testosterone level of less than 11 nmol per liter (3.2 ng per milliliter) and a free testosterone level of less than 220 pmol per liter (64 pg per milliliter).

Written by:
Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Boonen S, Vanderschueren D, Labrie F, Huhtaniemi IT Are you the author?

Reference: N Engl J Med. 2010 Jun 16. Epub ahead of print.
doi: 10.1056/NEJMoa0911101

PubMed Abstract
PMID: 20554979

UroToday.com Androgen Deficiency Section
 
BBB SealHon Code
Body Logic MD

Physicians Specializing in
Natural Bioidentical Hormones

* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

All Content © 2008 Medaus Pharmacy, Inc. & Other respective owners, All Rights Reserved. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician. Any medical or health advice provided and hosted on this site will only be given by medically trained and qualified professionals unless a clear statement is made that the advice offered is from a non-medically qualified individual or organisation. Where appropriate, information contained on this site will be supported by clear references to source data and, where possible, have specific HTML links to that data. The date when a clinical page was last modified will be clearly displayed.